表紙
市場調査レポート

幹細胞バンキング・ストレージ市場:規模・区分・動向

The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends

発行 BIOINFORMANT WORLDWIDE, LLC 商品コード 330701
出版日 ページ情報 英文 62 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
幹細胞バンキング・ストレージ市場:規模・区分・動向 The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends
出版日: 2015年05月21日 ページ情報: 英文 62 Pages
概要

当レポートでは、世界の幹細胞バンキング・ストレージ市場について調査し、現在の幹細胞バンキング市場規模、5カ年の市場規模データ、今後5カ年の市場規模予測、区分別の市場シェア、主な産業企業、および詳細な競合環境の分析など、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査範囲

第3章 本調査の目的

第4章 調査手法

第5章 保存された幹細胞の用途 (エンドユーズ)

  • バイオバンキング
  • 医療用途
  • 科学用途

第6章 幹細胞バイオバンキング市場の市場規模

  • 幹細胞ストレージの年間収益:市場区分別
  • 幹細胞ストレージ市場の市場規模

第7章 幹細胞バイオバンキング市場の基底変数

  • 幹細胞サンプルのおおよその保存期間
  • 温度要件
  • 論理的変数

第8章 産業のリーダー企業

  • 産業のリーダー企業が保存する幹細胞の主な種類
  • 産業のリーダー企業が提供する基本的サービスの分析

第9章 市場シェアの内訳:顧客別

第10章 市場の特徴付け

  • 「専門」ストレージ企業および総市場に占めるストレージの割合
  • 幹細胞バイオバンキング (ストレージ) 市場の割合 (vs. 関連サービス)

第11章 市場規模の成長率:5カ年データ分析の試み・5カ年予測

  • 世界の分析
  • 北米の分析

付録

目次

The purpose of this global strategic report is to prepare executives, company management, and industry investors with the data and knowledge necessary to make informed, educated decisions about commercial opportunities within the stem cell biobanking market.

This global strategic report is produced for:

  • Executives of Industrial-Scale Biobanks
  • Management of Stem Cell Product Companies
  • Management of Stem Cell Therapy Companies
  • Biobanking Industry Investors

It is designed to increase your efficiency and effectiveness in:

  • 1.Effectively pricing stem cell biobanking services
  • 2.Increasing revenue from stem cell biobanking services
  • 3.Identifying new or adjunct stem cell biobanking services to offer
  • 4.Identifying current market leaders within the stem cell biobanking market
  • 5.Characterizing the competitive environment for the stem cell biobanking market
  • 6.Identifying threats and opportunities within the stem cell biobanking market
  • 7.Acquiring greater market within the stem cell biobanking market
  • 8.Making intelligent investment decisions within the stem cell biobanking market

OVERVIEW

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types. Stem cells are still a relatively new discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first culturing of embryonic stem cells from non-human primates occurred. Induced pluripotent stem cells were not produced until 2006. As a result of these discoveries, stem cells can now be derived at various points during the life cycles.

The following are stages during which stem cells can be derived:

  • Embryonic stem cells, derived from blastocysts
  • Fetal stem cells, obtained from fetuses
  • Post-natal stem cells derived from newborn tissues, including cord blood stem cells from umbilical tissue
  • Adult stem cells found in adult tissues, including hematopoietic stem cells, mesenchymal stem cells, and neural stem cells
  • Induced pluripotent stem cells, reprogrammed from adult cells
  • Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body
  • And more

Forces Driving the Stem Cell Biobanking Market

Stem cell research and experimentation is largely driven by the unique ability of stem cells to divide and replicate repeatedly. In addition, their "unspecialized" nature allows them to differentiate into a wide variety of specialized cell types. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells.

Therefore, the possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Huntington's disease, Parkinson's disease, and spinal cord injuries are examples of conditions for which clinical applications involving stem cells could offer benefits in halting or even reversing adverse effects.

However, to have stem cells easily accessible for research purposes and clinical applications requires them to be preserved in stable, temperature controlled conditions.

For this reason, a substantial market has evolved for the biobanking of tissues containing stem cell populations and the storage of stem cells themselves.

Stem Cell Biobanking Market

Stem cell biobanking is the cryogenic storage of stem cells, or biological samples containing stem cells, for later use. The market for these services is known as the "Stem Cell Biobanking Market." Because stem cell biobanking often involves the long-term storage of stem cell samples, the market is sometimes is also known as the "Stem Cell Storage Market." For purposes of this analysis, these two terms are considered to be synonymous. A definition of this market is provided below.

Stem Cell Biobanking Market: The stem cell biobanking market is defined as the total annual revenue derived from the storage of:

  • 1. Stem cell lines and their derivatives
  • 2. All biological samples that were collected specifically because they contain stem cell populations (e.g. cord blood, adipose tissue, and more)

This report aims to understand and characterize the competitive environment for the stem cell biobanking market. As such, the research is focused on identifying leading participants in the stem cell storage market, distinguishing their business model, and exploring their relative market share.

Currently, the four leading providers of biobanking services are: Fisher Bioservices, Biostorage Technologies, EPL Archives, and Precision Bioservices. All four companies store millions of biological samples (15 million by Precision Bioservices, up to 170 million by Fisher Bioservices) and provide a diverse set of biobanking services. All but Precision Biosciences are multi-national companies with both U.S. and European operations. Because each company has large market share within the stem cell biobanking market, they are explored in detail within this report.

However, there are also companies specializing exclusively in stem cell storage. In one landmark event, Cellular Dynamics International (CDI) and the Coriell Institute for Medical Research announced receiving multi-million dollar grants from the California Institute for Regenerative Medicine (CIRM) for the creation of induced pluripotent stem cell (iPSC) lines from 3,000 healthy and diseased donors. CIRM awarded CDI $16 million to create three iPSC lines for each of 3,000 healthy and diseased donors and awarded the Coriell Institute $10 million to set up and biobank the iPSC lines. The result will be thecreation of the world's largest human iPSC bank, an incredible feat.

This iPSC biobank is one example of the expanding market for stem cell biobanking services. Because the goal of stem cell biobanking is to create a repository of stem cell specimens - including source tissue from which stem cells can be derived, differentiated cell types produced, and disease-specific cell lines created - large-scale stem cell biobanks provide researchers with the opportunity to investigate a diverse range of conditions using stem cells derived from both healthy and diseased donors. Importantly, biobanks can greatly expand the capacity for global research and collaboration.

Key report findings include:

  • Current Size of the Stem Cell Biobanking Market
  • Trailing 5-Year Market Size Data (2011-2015)
  • 5-year Market Size Projections (2016-2020)
  • Market Segmentation
  • Market Share by Segment
  • Key Industry Leaders
  • Detailed Competitive Environment Analysis
  • Analysis of Stem Cell Storage Applications (End-Uses)
  • Number of Stem Cell Samples Banked, by Industry Leader
  • Identification of Opportunities within the Stem Cell Biobanking Market
  • And Much More

Competing within the stem cell biobanking market can involve complicated and confusing decisions, but it doesn't need to. Claim this global strategic report to quickly understand current and future trends within the stem cell biobanking marketplace, identify opportunities by market segment, and derive more revenue from your stem cell biobanking services.

Table of Contents

1. INTRODUCTION

  • 1.1. Definitions
  • 1.2. Stem Cell Biobanking Market
  • 1.3. Stem Cell Biobanking Market Segments
    • TABLE: Stem Cell Biobanking Market Segments
  • 1.4. Stem Cell Biobanking Market Leaders

2. SCOPE

3. GOALS OF REPORT

4. METHODOLOGY

  • 4.1. Input Sources
  • 4.2. Research & Analysis Methodologies

5. APPLICATIONS FOR STORED STEM CELLS (END-USES)

  • 5.1. Biobanking
    • 5.1.1. Cord Blood Banking
      • IMAGE: Comparison of Umbilical Cord Blood vs. Umbilical Cord Tissue
    • 5.1.2. Bone Marrow & Peripheral Blood Specimens
    • 5.1.3. Dental Stem Cell Storage
      • TABLE: Companies Offering Dental Stem Cell Storage
    • 5.1.4. Adipose-Derived Stem Cell Storage
      • IMAGE: Companies Offering Adipose-Derived Stem Cell Storage
    • 5.1.5. Amniotic Fluid Storage
    • 5.1.6. Storage of Assisted Reproduction Specimens
  • Medical Applications
    • Cellular Therapy
    • Regenerative Medicine
    • Tissue Engineering
    • Personalized Therapeutics
  • Scientific Research
    • Basic Research
    • Applied Research

6. MARKET SIZE DETERMINATIONS FOR THE STEM CELL BIOBANKING MARKET

  • 6.1. Annual Revenue from Stem Cell Storage, by Market Segment
    • TABLE: Annual Revenue from Stem Cell Storage, by Market Segment
    • GRAPH: Annual Revenue from Stem Cell Storage, by Market Segment
  • Market Size Determinations for the Stem Cell Storage Market
    • Global Market Size
    • North American Market Size

7. BASIC VARIABLES FOR THE STEM CELL BIOBANKING MARKET.

  • Approximate Length of Time Stem Cell Samples are Stored
    • TABLE: Storage Durations, by Market Segment
  • Temperature Requirements
    • TABLE: Temperature Requirements for Stem Cell Biobanking
  • Logistical Variables

8. INDUSTRY LEADERS.

  • 8.1. Key Types of Stem Cells Stored by Industry Leaders
    • GRAPH: Stem Cell Biobanking Market - Market Share by Industry Leader
    • 8.1.1. Fisher BioServices
    • 8.1.2. BioStorage Technologies
    • TABLE: Range of Cryogenic Services Offered by BioStorage Technologies
    • 8.1.3. EPL Archives
    • TABLE: Range of Cryogenic Services Offered by EPL Archives
    • 8.1.4. Precision Bioservices
    • TABLE: Range of Cryogenic Services Offered by Precision Bioservices
  • 8.2. Analysis of Fundamental Services Provided by Industry Leaders (Storage, Logistics, Scientific
    • Services, Other)
    • Fisher BioServices
    • BioStorage Technologies
    • EPL Archives
    • Precision Bioservices

9. BREAKDOWN OF MARKET SHARE, BY CUSTOMER.

  • Graph: Stem Cell Biobanking Market - Breakdown of Market Share by End-User

10. MARKET CHARACTERIZATION

  • 10.1. "Pure Play" Storage Companies and Percentage of Total Market as Storage
    • TABLE: Market Segments for Stem Cell Storage, by End-User
  • 10.2. Percentage of Stem Cell Biobanking Market that is Storage (versus Related Services)
    • TABLE: Breakdown of Stem Cell Biobanking Market: Storage vs. Related Services
    • GRAPH: Breakdown of Stem Cell Biobanking Market: Storage vs. Related Services

11. MARKET SIZE GROWTH RATE DETERMINATIONS - TRAILING 5-YEAR DATA AND 5-YEAR PROJECTIONS (2016-2020)

  • 11.1. Global Analysis
    • TABLE: Trailing 5-Year Market Size Determinations for Global Stem Cell Biobanking Market (2011-2015)
    • GRAPH: Trailing 5-Year Market Size Determinations for Global Stem Cell Biobanking Market (2011-2015)
    • TABLE: 5-Year Projections for Global Stem Cell Biobanking Market (2016-2020)
    • GRAPH: 5-Year Projections for Global Stem Cell Biobanking Market (2016-2020)
  • 11.2. North American Analysis
    • TABLE: Trailing 5-Year Market Size Determinations for North American Stem Cell Biobanking Market (2011-2015)
    • GRAPH: Trailing 5-Year Market Size Determinations for North American Stem Cell Biobanking Market (2011-2015)
    • TABLE: 5-Year Projections for N. American Stem Cell Biobanking Market (2016-2020)
    • GRAPH: 5-Year Projections for N. American Stem Cell Biobanking Market (2016-2020)

APPENDICES

  • APPENDIX A - Complete List of Stem Cell Types
  • APPENDIX B - Global List of Biobanks and Biorepositories, by Geographical Region.
    • European Biobanks
    • North American Biobanks
    • United States Biobanks
    • Asian Biobanks
    • Australian Biobanks
    • Middle Eastern Biobanks
Back to Top